Neurologix (Neurologix) Debt-to-Asset : 1.23 (As of Jun. 2011)

View and export this data going back to . Start your Free Trial

What is Neurologix Debt-to-Asset?

Neurologix's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2011 was $6.08 Mil. Neurologix's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Jun. 2011 was $0.00 Mil. Neurologix's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Jun. 2011 was $4.96 Mil. Neurologix's debt to asset for the quarter that ended in Jun. 2011 was 1.22.

Neurologix Debt-to-Asset Historical Data

The historical data trend for Neurologix's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurologix Debt-to-Asset Chart

Neurologix Annual Data

Trend

Dec01

Dec02

Dec03

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Debt-to-Asset

Get a 7-Day Free Trial

0.49

Neurologix Quarterly Data
	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11
Debt-to-Asset	Get a 7-Day Free Trial															-	-	0.49	0.76	1.23

Competitive Comparison of Neurologix's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Neurologix's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Neurologix's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Neurologix's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Neurologix's Debt-to-Asset falls into.

Neurologix Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Neurologix's Debt-to-Asset for the fiscal year that ended in Dec. 2010 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(4.695	+	0)	/	9.677
	=	0.49

Neurologix's Debt-to-Asset for the quarter that ended in Jun. 2011 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(6.078	+	0)	/	4.963
	=	1.22

Neurologix (GREY:NRGXQ) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Neurologix Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Neurologix's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Neurologix (Neurologix) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Neurologix Inc (GREY:NRGXQ) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

One Bridge Plaza, Fort Lee, NJ, USA, 07024

Website

http://www.neurologix.net

Neurologix Inc is a development stage company that is engaged in the research and development of proprietary treatments for disorders of the brain and central nervous system, using gene transfer and other innovative therapies.

Neurologix (Neurologix) Headlines

No Headlines